Antitumor properties

An in vitro study by Franco-Molina et al. into the use of nanoparticle silver in cancer therapy found that colloidal silver induces dose-dependent cell death in the MCF-7 breast cancer cell line through apoptosis, without affecting the viability of normal PBMC cells. The study results place nanoparticle silver as a potential alternative agent for human breast cancer therapy.

M. A. Franco-Molina, E. Mendoza-Gamboa, C. A. Sierra-Rivera et al., “Antitumor activity of colloidal silver on MCF-7 human breast cancer cells,” Journal of Experimental and Clinical Cancer Research, vol. 29, no. 1, article 148, 2010.